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Abstract 
Background: Hypertension is recognized as an important contributor to high cardiovascular mortality in Russia. A 
comprehensive analysis of data from Russian studies that measured blood pressure in population-based samples 
has not been previously undertaken. This study aims to identify trends and patterns in mean blood pressure and the 
prevalence of hypertension in Russia over the most recent 40 years.
Methods: We obtained anonymized individual records of blood pressure measurements from 14 surveys conducted 
in Russia in 1975–2017 relating to a total of 137,687 individuals. For comparative purposes we obtained equivalent 
data from 4 surveys in the USA and England for 23,864 individuals. A meta-regression on aggregated data adjusted 
for education was undertaken to estimate time trends in mean systolic and diastolic blood pressure, the prevalence 
of elevated blood pressure (> 140/90 mmHg), and hypertension (defined as elevated blood pressure and/or the use of 
blood pressure-lowering) medication. A meta-analysis of pooled individual-level data was used to assess male-female 
differences in blood pressure and hypertension.
Results: During the period 1975–2017 mean blood pressure, the prevalence of elevated blood pressure and hyper-
tension remained stable among Russian men. Among Russian women, mean systolic blood pressure decreased at an 
annual rate of 0.25 mmHg (p < 0.1) at age 35–54 years and by 0.8 mmHg (p < 0.01) at ages 55 and over. The prevalence 
of elevated blood pressure also decreased by 0.8% per year (p < 0.01), but the prevalence of hypertension remained 
stable. Mean blood pressure and prevalence of hypertension were higher in Russia compared to the USA and England 
at all ages and for both sexes.
Conclusions: In contrast to the generally observed downward trend in elevated blood pressure in many other 
countries, levels in Russia have changed little over the past 40 years, although there are some positive trends among 
women. Improved strategies to bring down the high levels of mean blood pressure and hypertension in Russia com-
pared to countries such as England and the USA are important to further reduce the high burden of CVD in Russia.
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Background
Blood pressure is a strong predictor of cardiovascular 
mortality [1] and elevated levels are a leading determi-
nant of premature cardiovascular disease (CVD) globally 
[2, 3]. Russia has had one of the highest cardiovascular 
disease mortality rates in the world, even though since 
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2005 rates have been declining [4]. A Global Burden of 
Diseases (GBD) analysis on Russia concluded that in 2016 
high systolic blood pressure was responsible for over 33% 
of all deaths [5].
During the last 5 years, several global studies have 
been published in which mean blood pressure and the 
prevalence of hypertension have been compared between 
countries and regions. Based on pooled data from 1479 
studies the NCD Risk Factor Collaboration (NCD-RisC) 
[6] found that systolic blood pressure (SBP) and diastolic 
blood pressure (DBP) were high in countries of Cen-
tral and Eastern Europe (CEE) relative to other regions, 
although levels had reduced among women of the region 
over the past 4 decades. An analysis of international vari-
ation in hypertension in 2010 (based on World Health 
Organization (WHO) Study on global AGEing and adult 
health (SAGE) data) found Russia to have one of the high-
est prevalences [7]. An analysis of data from the GBD 
found that the age-standardized prevalence of elevated 
blood pressure was particularly high in Russia, and other 
former Soviet countries, compared to those of Western 
Europe: 29–31% in Russia, Ukraine, Belarus, and Esto-
nia vs. 15.2% in the UK, 20% in France and Denmark [8]. 
These large data-synthesis analyses were based on stud-
ies from a diverse range of surveys from across the world 
that the project teams had been able to assemble.
In Russia since the late 1970s, a number of population-
based health surveys have been conducted that measured 
blood pressure and collected information on the use of 
anti-hypertensive medications. The earliest estimates 
of hypertension prevalence in Russia were from the col-
laborative USSR-USA Lipid Research Clinics Prevalence 
Study (LRC) conducted in 1975–77 and 1982–84 [9–11]. 
Subsequent rounds of the LRC, as well as the World 
Health Organization MONItoring of Trends and Deter-
minants in Cardiovascular disease (MONICA) were con-
ducted in the 1990s and the early 2000s [12]. In the 2000s 
and the 2010s, several other large population-based and 
multi-regional surveys have been carried out [13–17]. 
Since 2012 the Russian Ministry of Health has funded 
several rounds of the ESSE survey focused on cardiovas-
cular disease in different regions of Russia [13], although 
unlike the National Health and Nutrition Examination 
Survey (NHANES) in the USA or the Health Survey for 
England (HSE) these were not based on nationally rep-
resentative population samples. In addition, there have 
been studies conducted in specific cities or regions of the 
country [18–23]. To date, no attempt has been made to 
bring these data together to provide a systematic analysis 
of trends in mean systolic and diastolic blood pressure, 
prevalence of  elevated blood pressure, and hyperten-
sion by age and sex in Russia. In the present study, we 
undertook such a comprehensive assessment based on 
datasets from Russian surveys conducted over the past 
40 years.
Methods
We obtained from investigators data from studies that 
had measured blood pressure in population-based sam-
ples in Russia with adequate documentation of their 
design and protocols. To be included studies had to 
have aimed at being representative of their target popu-
lation, defined either as the entire country, one or sev-
eral regions, or defined geographic areas. Although the 
precise designs and settings varied among studies, our 
analysis aims at identifying any common patterns that 
may reflect true underlying characteristics in the gen-
eral population of Russia. Studies were identified based 
on our extensive knowledge of Russian population-based 
research. We supplemented this in January-February 
2019 with a Google search for “hypertension AND Rus-
sian population” and “blood pressure AND Russian pop-
ulation”. This did not yield any studies that we were not 
already aware of. We approached investigators of all the 
studies we considered to be eligible for inclusion. As we 
discuss later in the paper only one study refused to pro-
vide their data.
Data sets
Our analysis is based on individual blood pressure meas-
urements from 14 independent cross-sectional sur-
veys conducted in Russia that jointly included a total of 
137,687 participants (Supplementary Table  S1). Among 
these surveys only the WHO 2007–2010 SAGE aimed 
at being representative of the general population of the 
whole country. Other epidemiological studies were 
restricted to one or more sub-national areas. The sample 
sizes varied from 483 in Pitkäranta (conducted in 2007) 
to 31,949 in the Monitoring of the Arterial Hypertension 
(Monitoring AH, 2005–2008). Half of the surveys cover 
the range of ages 18 years and older. However, SAGE and 
Stress, Ageing and Health Study (SAHR) included only 
those aged 55+ years. The Pitkäranta studies and the 
Izhevsk Family Study 2 (IFS) include only individuals at 
working ages 25–64 years, while the Know Your Heart 
(KYH) study was restricted to those aged 35–69 years. To 
put our results in the international context, we obtained 
measurements on 23,864 participants from the 2009 and 
2016 from the Health Survey for Englad (HSE) [24, 25] 
and 2007–2008 and 2015–2016 rounds of the the US 
NHANES [26, 27]. Characteristics of data sets and popu-
lations analyzed are provided in Supplementary Table S1.
Page 3 of 10Churilova et al. BMC Public Health         (2021) 21:2226  
Ethics and consent
This study involved the secondary analysis of a small 
number of variables in anonymized datasets from a 
variety of sources. All procedures in surveys included 
in analysis were performed in accordance with relevant 
guidelines. No ethical approval is needed to access any 
data used in this study.
Definitions
Elevated blood pressure was defined as SBP of 140 mmHg 
or higher or DBP of 90 mmHg or higher. Where available 
we used the mean of two or more blood pressure meas-
urements as appropriate. More details on the number 
of blood pressure measurements and the type of equip-
ment used in each study are provided in Supplementary 
Table S2.
We used self-reported use of blood pressure-lowering 
drugs. This information was obtained in answer to a vari-
ety of questions: “Have you been taking any medications 
or other treatment for elevated blood pressure during the 
last 2 weeks?” (MONICA, Monitoring AH, SAHR, SAGE 
and during 1 week for LRC), “Have you been taking any 
medications lowering blood pressure? (Arkhangelsk 
study, ESSE), “Do you take prescribed drugs to control 
your blood pressure?” (IFS2). In SAGE and NHANES the 
question about blood pressure medication was asked to 
those who had been informed by a doctor about blood 
pressure elevation, in other studies to all respondents. 
For 4/14 of the studies information about the precise 
question asked about medication was not available.
In all studies, hypertension was defined as measured 
elevated blood pressure and/or the use of blood pressure-
lowering medication.
In each study, we aggregated education level reported 
by respondent into three categories: high, middle, and 
low education. High education corresponds to a univer-
sity degree or another type of higher education degree. 
Middle education corresponds to completed secondary 
education or vocational secondary education. Low edu-
cation means less than completed secondary education.
Statistical analyses
Our analysis started with an inspection of the age pro-
files (10-year intervals from 35 to 44 to 75+) of the mean 
SBP and DBP and the prevalence of elevated blood pres-
sure and hypertension (Supplementary Tables S3, S4, S5 
and S6). We found that education tended to be inversely 
associated with mean and elevated blood pressure  that 
also agrees with earlier study [28]. To remove potential 
confounding effects of differences in the educational 
composition of the different study populations, in part 
generated by selection bias, we standardized all estimates 
to the educational structure reported at the 2002 All-
Russia Census [29].
To examine temporal trends we looked at whether 
mean levels of blood pressure and hypertension tended 
to be lower in later surveys compared to earlier sur-
veys. These analyses were stratified by sex and age 
(groups 35–54 and 55+ years) with cutoffs chosen so that 
we had adequate numbers in each age group on which 
to estimate means and proportions. The study-specific 
outcomes (mean SBP, mean DBP, prevalence of elevated 
blood pressure, prevalence of hypertension, prevalence 
of treated patients among hypertensives) were regressed 
on the central year of each survey with adjustment for 
mean age and the share of high education using a ran-
dom-effects meta-regression model (metareg command 
in Stata) [30] on study-level summary data.
To investigate whether male-female differences in the 
blood pressure outcomes changed over time we com-
pared the magnitude of the sex difference between and 
within studies according to central year of survey. We 
used ordinary least squares (OLS) meta-analysis regres-
sion (ipdmetan command in Stata) [31] on individual-
level data with the “forest plot” option to estimate the 
male-female differences in mean systolic and diastolic 
blood pressure adjusting for education and age. An equiv-
alent set of logistic meta-analysis models were used to 
estimate differences between studies in the male-female 
odds ratio for elevated blood pressure and hypertension. 
In order to deal with the fact that studies varied consid-
erably in the age range of subjects they covered, these 
analyses were restricted to the age range 55–64 years as 
this age group was the one where data existed for all (14) 
Russian studies.
 All tabulations and  regression  models were imple-
mented in Stata 14 [32].
Results
Mean systolic blood pressure
Figure 1 shows the education adjusted mean SBP values 
for men and women by age in each study. As expected, 
in all studies mean SBP tended to increase with age. All 
means from the Russian studies were higher than those 
in NHANES (USA) and HSE (England), with the excep-
tion of men in the youngest age groups. In general, the 
difference between the mean SBP in the Russian and the 
comparator Western surveys increased with age.
In both women and men, the highest SBP means in 
Russia tended to be found in the earliest studies con-
ducted up until the early 2000s. Among women, the low-
est values were found in the most recent study (KYH, 
2015–17).
The trends over time for blood pressure means by cen-
tral year of study were examined using meta-regression 
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Fig. 1 Age-specific mean SBP (mm Hg) in Russian surveys compared to HSE and NHANES. Notes: For Russian surveys, averages are standardized by 
education. For more details, see the Methods section
Table 1 Trends over  timea in the blood pressure indicators by sex within age groups 35–54 and 55 years and older
a Results of meta-regression on data from 14 Russian surveys. Regression models are controlled for education and age. See the Methods section for more details
Population group (sex x age) Number of surveys in analysis Slope (annual change) and 95% CI P
Mean SBP (mm Hg) per year
 Women, 35–54 12 −0.252 (− 0.535, 0.031) 0.074
 Women, 55+ 13 −0.786 (− 1.156, − 0.415) 0.001
 Men, 35–54 13 −0.087 (− 0.517, 0.343) 0.658
 Men, 55+ 14 −0.235 (− 0.615, 0.145) 0.199
Mean DBP (mm Hg) per year
 Women, 35–54 12 −0.157 (− 0.389, 0.075) 0.158
 Women, 55+ 13 −0.127 (− 0.315, 0.061) 0.161
 Men, 35–54 13 −0.078 (− 0.336, 0.181) 0.515
 Men, 55+ 14 −0.005 (− 0.131, 0.121) 0.934
Prevalence of elevated blood pressure (%) per year
 Women, 35– 54 12 −0.425 (0.962, 0.111) 0.105
 Women, 55+ 13 −0.785 (−1.223, − 0.348) 0.003
 Men, 35–54 13 −0.359 (−1.211, 0.492 0.365
 Men, 55+ 14 −0.217 (− 0.580, 0.145) 0.211
Prevalence of hypertension (%) per year
 Women, 35–54 12 −0.123 (− 0.520, 0.275) 0.497
 Women, 55+ 13 −0.073 (− 0.195, 0.048) 0.206
 Men, 35–54 13 −0.089 (− 0.717, 0.537) 0.753
 Men, 55+ 14 0.221 (−0.119, 0.561) 0.179
Prevalence of anti-hypertensive medication use among hypertensives (%) per year
 Women, 35–54 12 1.604 (0.054, 3.155) 0.044
 Women, 55+ 13 1.780 (0.760, 2.800) 0.003
 Men, 35–54 13 1.532 (0.184, 2.881) 0.030
 Men, 55+ 14 1.889 (0.425, 3.352) 0.017
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stratified by sex and age group 35–54 and 55+ years 
(Table  1). The results show a statistically significant 
decline over time in the mean SBP both among women 
aged 55 years and older of 0.8 mmHg per year (p < 0.01) 
and a marginally significant decline of 0.25 mmHg per 
year in the younger age group 35–54 (p < 0.1). There was 
little evidence for a decline in either age group among 
men.
Mean diastolic blood pressure
Figure 2 shows the education adjusted mean DBP values 
for men and women by age in each study. The range of 
means in the Russian studies at all ages was much nar-
rower than seen for SBP: nearly all values lie in the range 
80–90 mmHg. In most Russian studies the DBP means 
increased slightly with age or level off at age 65–74 years. 
In contrast, the NHANES and HSE surveys showed 
marked declines from age 55–64 years onwards. This 
resulted in a clear widening of DBP differences with age 
between the Russian means and those in the comparator 
countries.
Unlike SBP there was no obvious trend of DBP with 
year of survey. The meta-regression results (Table 1) con-
firm that there was little evidence of any trend over time 
in mean DBP for either men or women.
Prevalence of elevated blood pressure
Figure  3 shows the education-adjusted prevalence 
of elevated blood pressure (> = 140/90) for men and 
women by age in each study. In all studies, there was a 
clear tendency for prevalence to increase steeply with 
age. This increase was generally steeper for the Russian 
studies than for the comparator studies in the USA and 
England, resulting in a wider international gap at older 
than younger ages. The exception to this was the KYH 
(2015–17) study where the prevalences at every age in 
women were only slightly higher than those seen for the 
NHANES (USA) and HSE (England).
Among the Russian studies at any age, the highest 
prevalences were generally found in the earliest stud-
ies, although men in the IFS2 study (2008–9) had the 
highest levels. Among women, the lowest prevalence of 
elevated blood pressure was for the most recent survey 
(KYH 2015–17). The meta-regressions (Table  1) show 
that there was a downward trend with time in the prev-
alence of elevated blood pressure in the Russian studies 
in younger and older men and women, although this was 
only significant for women aged 55+ years.
Prevalence of hypertension
Figure 4 shows the age-specific education adjusted preva-
lence of hypertension in each study. Among men at every 
age, the NHANES and HSE prevalences were lower than 
seen in any Russian study. For women prevalences were 
much higher at each age in the Russian studies compared 
to NHANES or HSE, although it is intriguing to note that 
NHANES levels lie almost exactly between those of the 
Russian studies and the English (HSE) estimates.
For women, at any given age the Russian studies all 
showed very similar prevalences although once again the 
most recent study (KYH 2015–17) had the lowest preva-
lences. In contrast, there was a more heterogeneous pat-
tern among men across the different Russian studies. 
The two most recent studies (ESSE 2012–2014 and KYH 
Fig. 2 Age-specific mean DBP (mm Hg) in Russian surveys compared to HSE and NHANES. Notes: For Russian surveys, averages are standardized by 
education. For more details, see the Methods section
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2015–2017) showed slightly higher prevalences in middle 
age than those observed a decade earlier. Consistent with 
the impression from Fig.  4 there was no evidence from 
the meta-regression results (Table  1) for a change over 
time in prevalence in hypertension in the Russian studies 
for either men or women.
The numeric values underlying Figs.  1, 2, 3 and 4 are 
given in Supplementary Tables S3 to S6.
Changes in anti‑hypertensive medication
We analyzed the time trend in the percentage of people 
with hypertension who reported use of anti-hyperten-
sive medications. Our results (Table  1) show that there 
was a significant upward trend with time in the preva-
lence of blood pressure medications use among Russian 
hypertensive. The results show a statistically signifi-
cant increase in blood pressure medications use of 1.6% 
(p < 0.05) per year among women with hypertension aged 
Fig. 3 Age-specific prevalence of elevated blood pressure in Russian surveys compared to HSE and NHANES. Notes: For Russian surveys, averages 
are standardized by education. For more details, see the Methods section
Fig. 4 Age-specific prevalence of hypertension in Russian surveys compared to HSE and NHANES. Notes: For Russian surveys, percentages are 
standardized by education. For more details, see the Methods section
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35–54 years and of 1.8% (p < 0.01) per year among hyper-
tensive women aged 55+. Similarly among men, anti-
hypertensive medications use also significantly increased 
by 1.5% (p < 0.05) at age 35–54 years and by 1.9% (p < 0.05) 
among those aged 55+ years.
Gender differences
We have already noted that there are some differences 
between men and women in levels and trends. The 
majority of studies included participants in the age range 
55–64 years, allowing us to analyze gender differences 
in blood pressure dynamics holding age constant. The 
results are shown in Supplmentary Figs. S1, S2, S3 and S4. 
During the 1980s and the 1990s, mean SBP was lower in 
men than women. However, mean SBP in women started 
decreasing in the 2000s, which resulted in a reduction in 
the SBP gender gap. The surveys conducted in the 2010s 
show SBP in men to be higher than in women for the first 
time (Supplementary Fig.  S1). Similar gender-specific 
temporal changes were found in mean DBP and in the 
elevated blood pressure (Supplementary Figs. S2 and S3). 
The male-female differences in the prevalence of hyper-
tension show female excess in the 1980s, the 1990s, and 
the 2000s (Supplementary Fig. S4). However, in the 2010s 
this gender difference in hypertension prevalence among 
55–64 years-old disappeared.
Discussion
Our analyses are the most detailed examination to date 
of all key dimensions of blood pressure and hyperten-
sion in Russia spanning over 40 years from 1975 to 2017. 
Our clearest finding is that mean blood pressures and the 
prevalence of elevated blood pressure and hypertension 
in the Russian surveys are higher than in the compara-
tor surveys from the USA and England even in the most 
recent years. This is consistent with the continued excess 
of cardiovascular disease mortality in Russia compared to 
Western countries and underlines how important raised 
blood pressure is likely to be as a key driver of the very 
high burden of cardiovascular disease in Russia.
A key aims of this study has been to examine trends 
over time in Russia. Our results provide some evidence 
for improvements in mean blood pressure and preva-
lence of elevated blood pressure from the earliest to 
the most recent surveys. This evidence is strongest for 
women aged 55 years and older, with less sizeable and 
convincing trends apparent for men. This is broadly con-
sistent with the conclusion of the NCD-RisC analysis [6] 
that reported that there was a tendency of mean blood 
pressures to decrease among women from the former 
communist countries of Eastern Europe.
Given these trends in mean and elevated blood pres-
sures, it is striking that we found almost no evidence in 
either men or women of changes over time in the preva-
lence of hypertension per se defined in terms of elevated 
blood pressure (140/90) and/or taking antihypertensive 
medication. This might be explained by increases over 
time in the use of anti-hypertensives in Russia that were 
particularly pronounced among women. The higher the 
proportion of the population taking anti-hypertensive 
medication the higher the nominal prevalence of hyper-
tension regardless of whether this translates into an 
impact on mean or elevated blood pressure. Certainly, 
even in the most recent survey, there are high rates of 
uncontrolled hypertension especially among men [33].
The decrease in mean blood pressure among women 
led to the initial gender difference in the prevalence of 
elevated blood pressure with women having the highest 
levels was reversed from the 2010s. This positive change 
among women combined with the growing use of medi-
cations among them may indicate more effective hyper-
tension control than among men.
Our most unexpected finding concerned contrasts 
between mean SBP and mean DBP. Firstly, diastolic blood 
pressures for both men and women showed less variation 
across the Russian surveys than systolic blood pressure. 
Moreover, the gap between the Russian studies and those 
in England and the US was larger and more pronounced 
for DBP than SBP. Secondly, there were striking differ-
ences in the relationship of age to mean DBP in the Rus-
sian compared to the US and England. Whereas in the US 
and English surveys mean DBP showed a clear decline 
from the fifth decade of age, none of the Russian surveys 
included in analysis showed this effect. Instead, most of 
the Russian surveys showed either continued increases 
with age or a plateauing or small decline in DBP from 
around age 50 years. This is consistent with the small lon-
gitudinal declines seen in DBP in the Russian HAPIEE 
study [34].
In contrast to what we have noted for Russia, there is 
abundant other evidence of a pronounced decline in DBP 
after the age of 50 years in Western high-income coun-
tries both in cross-sectional and in longitudinal studies 
[35]. One explanation for this decline with age is that the 
process of vascular aging [36] involves increases in arte-
rial stiffness [37]. Reduction in the elasticity of the aorta 
results in reduced blood pressure in diastole. However, it 
has been postulated that it is only from around 50 years 
of age that the downward influence on DBP overcomes 
the general upward tendency on both SBP and DBP to 
increase due to increases in peripheral vascular resist-
ance with age [37]. Could it, therefore, be that in Russia at 
a population level there may be a steeper increase in the 
influence of peripheral vascular resistance with age than 
is seen in countries such as those in Western Europe and 
North America? This is consistent with the fact that our 
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analyses show a steeper net increase in SBP with age than 
observed in the comparator national surveys from Eng-
land and the USA.
One of the important influences on blood pressure 
levels in a population is diet especially salt intake [38]. It 
is out of the scope of this paper to consider how far the 
blood pressure trends and patterns may be explained 
by salt intake and other aspects of primary prevention. 
However, it should be noted that the failure to show 
declines in mean blood pressure other than among older 
women in Russia suggests that any attempts at the pri-
mary prevention of hypertension have not been effective.
The inevitable weakness of our study, and indeed of all 
other parallel data syntheses including the Global Bur-
den of Disease and NCD-RisC [6], is that the studies we 
have been able to include use a range of designs, sam-
pling frames, and sample sizes. Moreover, we and oth-
ers depend upon the willingness of other researchers to 
share their data. In our case we obtained data from all of 
the studies that we classed as eligible with one exception 
[34].
The optimal approach to study population trends in a 
parameter such as blood pressure would be to have data 
from a single study of a consistently defined geographic 
location sampled at random which used a consistent 
recruitment and measurement methodology at succes-
sive time points. This is the basic design of the Health 
Survey for England and the US NHANES we used as 
international comparators in this study. However, in Rus-
sia, there are no equivalent repeated large-scale nation-
ally representative surveys. The Russian Longitudinal 
Monitoring Survey (RLMS) which we have previously 
used to study trends in smoking [39] has not measured 
blood pressure. Moreover, the AH Monitoring studies 
conducted in 2003–05, 2005–08, and 2009–10, that are 
included in our analysis, differ from each other in terms 
of the regions participating in these studies. In this situ-
ation, we have therefore had to use the best available 
alternative of synthesizing data from different studies 
conducted over a span of years.
Some of the studies we used recruited participants via 
health care facilities while others used population lists 
as a basis for sampling. Only one of the Russian studies 
explicitly attempted to draw a nationally representative 
sample, while many of the studies were restricted to one 
or two regions or cities. This diversity in survey location, 
design, and size will almost certainly have introduced 
sources of heterogeneity that will make temporal trends 
challenging to identify with certainty. To minimize some 
of the extraneous sources of variation, we used meth-
ods of meta-analysis that account for the heterogeneity 
of data sources. To adjust for inter-survey differences in 
the socio-demographic composition among surveys, we 
standardized our outcome measures to reflect the fixed 
educational distribution of the population at the 2002 
Russian Census: roughly the mid-point of the period over 
which our constituent studies were conducted. This will 
have also helped reduce variations due to selection bias 
in the recruitment of participants whereby survey par-
ticipation tends to be higher among those who are most 
educated. However, this may have introduced a degree 
of underestimation of real population trends over time 
through the elimination of changes caused by a general 
rise of the educational level of the Russian population.
Conclusion
Over the past 4 decades of observation, the prevalence of 
hypertension in Russia has been stable among men and 
women. Among women, this was due to two opposing 
trends: a decrease in mean systolic blood pressure and 
elevated blood pressure prevalence but an increase in 
the use of anti-hypertensives, potentially resulting in bet-
ter control of raised blood pressure. In contrast, among 
men, there was little change in mean and elevated blood 
pressure and no improvement in its control. Despite 
improvements among women, the mean blood pressure 
(particularly diastolic at older ages) and the prevalence of 
elevated blood pressure remain high in Russia compared 
to England and the USA. Insufficient blood pressure con-
trol in Russia  is an obstacle to further reduction of the 
CVD risks related to hypertension, especially among 
men.
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